RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Kidney Reperfusion Injury
Accession: DOID:9006223
browse the term
Definition: Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the kidney, including swelling; hemorrhage; necrosis; and damage from free radicals.
Synonyms: exact_synonym: Kidney Ischemia-Reperfusion Injury; Renal Ischemia-Reperfusion Injury; Renal Reperfusion Injury
G
Ace
angiotensin I converting enzyme
ISO
RGD
PMID:21680852
RGD:6893484
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
ISO
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Acta1
actin alpha 1, skeletal muscle
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490
G
Acvr2b
activin receptor IIB
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
G
Adam17
a disintegrin and metallopeptidase domain 17
treatment
ISO
RGD
PMID:22015440
RGD:13703100
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
G
Adam2
a disintegrin and metallopeptidase domain 2
ISO
RGD
PMID:11967014
RGD:10047130
NCBI chr14:66,264,778...66,315,300
Ensembl chr14:66,264,778...66,315,182
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:18272597
RGD:9684850
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adm
adrenomedullin
treatment
ISO
protein:increased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Akr1a1
aldo-keto reductase family 1, member A1
IMP
RGD
PMID:31089212
RGD:27226686
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
IMP
RGD
PMID:22022451
RGD:7241603
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Anxa1
annexin A1
treatment
ISO
RGD
PMID:20953576
RGD:7421585
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Anxa5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Apaf1
apoptotic peptidase activating factor 1
treatment
ISO
RGD
PMID:26362957
RGD:13703110
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Apoa1
apolipoprotein A-I
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Atm
ataxia telangiectasia mutated
ISO
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:18221257 PMID:29285062
RGD:2293026 , RGD:13792599
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdkrb1
bradykinin receptor, beta 1
IMP
RGD
PMID:18725957
RGD:7241559
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Becn1
beclin 1, autophagy related
treatment
ISO
RGD
PMID:26412257
RGD:11561958
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bmi1
Bmi1 polycomb ring finger oncogene
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
C3
complement component 3
treatment
ISO
RGD
PMID:19691975
RGD:7411689
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Calca
calcitonin/calcitonin-related polypeptide, alpha
ISO
RGD
PMID:19194162
RGD:7204479
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
ISO
RGD
PMID:17596683
RGD:5684536
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Ccl11
C-C motif chemokine ligand 11
treatment
IDA
RGD
PMID:22160777
RGD:7247742
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl2
C-C motif chemokine ligand 2
treatment ameliorates
IEP ISO
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:20396927 PMID:18650485 PMID:24920753
RGD:4891433 , RGD:11526113 , RGD:329845564
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccn1
cellular communication network factor 1
ameliorates
IMP
RGD
PMID:24920753
RGD:329845564
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Cd14
CD14 antigen
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
treatment
ISO
RGD
PMID:25993320
RGD:11251055
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cfb
complement factor B
IMP
RGD
PMID:16467447 PMID:12538716
RGD:7242709 , RGD:7242734
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cfh
complement component factor h
treatment
ISO
protein:decreased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Ciita
class II transactivator
IEP
RGD
PMID:14569092
RGD:7242896
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787
G
Col1a1
collagen, type I, alpha 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col3a1
collagen, type III, alpha 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Csf1
colony stimulating factor 1 (macrophage)
IMP ISO
mRNA:increased expression:kidney
RGD
PMID:23143303 PMID:19196448
RGD:7257565 , RGD:7257570
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Csf1r
colony stimulating factor 1 receptor
IMP
RGD
PMID:23143303
RGD:7257565
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
IMP ISO
RGD
PMID:22189844 PMID:9407517
RGD:7204675 , RGD:7204727
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP
RGD
PMID:20038794
RGD:7257679
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
treatment
ISO
RGD
PMID:23552495
RGD:7244372
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Daxx
Fas death domain-associated protein
IEP ISO
protein:increased expression:kidney:
RGD
PMID:18480747 PMID:18480747
RGD:9587836 , RGD:9587836
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
G
Ddr1
discoidin domain receptor family, member 1
IEP
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Dhfr
dihydrofolate reductase
treatment
ISO
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Drd3
dopamine receptor D3
treatment
ISO
RGD
PMID:25989500
RGD:13506961
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Eed
embryonic ectoderm development
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 7:89,603,862...89,630,184
Ensembl chr 7:89,603,862...89,630,191
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Egln3
egl-9 family hypoxia-inducible factor 3
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646
G
Elane
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:16980042
RGD:10450580
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Eng
endoglin
ISO IMP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653 PMID:16751653
RGD:7248779 , RGD:7248779
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
G
Ep300
E1A binding protein p300
ISO
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 , RGD:11041698
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
G
F3
coagulation factor III
ISO
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fas
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fcgr1
Fc receptor, IgG, high affinity I
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
G
Fga
fibrinogen alpha chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fgb
fibrinogen beta chain
treatment
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370 PMID:21685370
RGD:7175292 , RGD:7175292
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
G
Fgfr2
fibroblast growth factor receptor 2
exacerbates ameliorates
IEP IMP ISO
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:32523960 PMID:29344510 PMID:22688984
RGD:155663667 , RGD:155782882 , RGD:155782904 , RGD:155882537
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fgg
fibrinogen gamma chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
G
Fn1
fibronectin 1
ISO
RGD
PMID:11352844
RGD:7205629
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fos
FBJ osteosarcoma oncogene
IEP
RGD
PMID:19095962
RGD:7242184
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:20332418 PMID:20332418
RGD:9685723 , RGD:9685723
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Glo1
glyoxalase 1
ISO
RGD
PMID:19211689 PMID:19211689
RGD:7242566 , RGD:7242566
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:37033969 PMID:22442209
RGD:401827821 , RGD:401827906
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24630969
RGD:10401866
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm1
glutathione S-transferase, mu 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
ISO
protein:decreased expression:kidney
RGD
PMID:37033969
RGD:401827821
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:23726287
RGD:8693706
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Has1
hyaluronan synthase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr17:18,063,588...18,075,450
Ensembl chr17:18,063,585...18,075,467
G
Has2
hyaluronan synthase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
G
Havcr1
hepatitis A virus cellular receptor 1
ISO IEP
protein:increased expression:urine:
RGD
PMID:23552495 PMID:23085062 PMID:23019274
RGD:7244372 , RGD:7245489 , RGD:7245495
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment severity
ISO
RGD
PMID:17519789 PMID:22432008
RGD:1626334 , RGD:9068883
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:21291499
RGD:10755580
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hsf1
heat shock factor 1
ISO
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa8
heat shock protein 8
ISO
RGD
PMID:7569112
RGD:7242788
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hyal1
hyaluronoglucosaminidase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 9:107,454,149...107,458,898
Ensembl chr 9:107,454,126...107,458,909
G
Hyal2
hyaluronoglucosaminidase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 9:107,445,096...107,449,975
Ensembl chr 9:107,445,144...107,449,978
G
Ifng
interferon gamma
treatment
IEP
RGD
PMID:28355607
RGD:14975115
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1r
insulin-like growth factor I receptor
ISO
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Ikbkb
inhibitor of kappaB kinase beta
treatment
ISO
RGD
PMID:19546526
RGD:7495779
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Il10
interleukin 10
treatment
ISO IEP
RGD
PMID:24079335 PMID:28664613
RGD:7364864 , RGD:14975137
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12b
interleukin 12b
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:22089199
RGD:8655971
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
ameliorates
ISO IEP
RGD
PMID:20030532 PMID:24920753
RGD:7175501 , RGD:329845564
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO IMP
rat model treated with human protein mouse model treated with human protein
RGD
PMID:18363573 PMID:16849996 PMID:9555664
RGD:6907101 , RGD:6907359 , RGD:6909149
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Inhbb
inhibin beta-B
ISO
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
G
Itgb2
integrin beta 2
ISO
Associated with renal transplant patients
RGD
PMID:20504838 PMID:11007822
RGD:6907049 , RGD:6907073
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Kcnj11
potassium inwardly rectifying channel, subfamily J, member 11
ISO
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
G
Kl
klotho
treatment
ISO IMP
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278 PMID:16204278
RGD:10403064 , RGD:10403064
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
G
Kmt2a
lysine (K)-specific methyltransferase 2A
IEP
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
G
Lcn2
lipocalin 2
ISO IEP
protein:increased expression:urine: mRNA,protein:increased expression:kidney: mRNA,protein:increased expression:kidney,urine
RGD
PMID:23364806 PMID:23085062 PMID:20181666 PMID:27800610
RGD:7245469 , RGD:7245489 , RGD:126779563 , RGD:126790572
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lep
leptin
resistance
ISO
RGD
PMID:22969992
RGD:6909133
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lgals3
lectin, galactose binding, soluble 3
ISO
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP ISO
RGD
PMID:20075199 PMID:26412257
RGD:11561916 , RGD:11561958
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:23952292
RGD:10412647
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Mc1r
melanocortin 1 receptor
ISO
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
G
Mir146
microRNA 146
treatment
ISO
RGD
PMID:27760486
RGD:155882556
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir320
microRNA 320
treatment
ISO
RGD
PMID:31089916 PMID:27760486
RGD:155882543 , RGD:155882556
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
Mir381
microRNA 381
ISO
RNA:decreased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr12:109,693,256...109,693,330
Ensembl chr12:109,693,256...109,693,330
G
Mir423
microRNA 423
treatment
ISO
RGD
PMID:29137244
RGD:158014894
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir494
microRNA 494
ameliorates
IMP
RGD
PMID:23160513
RGD:155883172
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Mpo
myeloperoxidase
ISO IMP
protein:increased activity:kidney
RGD
PMID:22950848 PMID:18055546
RGD:6909167 , RGD:7174699
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Muc1
mucin 1, transmembrane
treatment
ISO
RGD
PMID:22019164
RGD:7245959
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Myc
myelocytomatosis oncogene
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO IEP
RGD
PMID:24096033 PMID:22160772
RGD:13801197 , RGD:13801199
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Nes
nestin
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
RGD
PMID:31089916
RGD:155882543
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nos2
nitric oxide synthase 2, inducible
treatment
ISO
RGD
PMID:18408363
RGD:11040540
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
RGD
PMID:29291552 PMID:18408363
RGD:13504682 , RGD:11040540
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nox1
NADPH oxidase 1
treatment
ISO
RGD
PMID:34244746
RGD:329955363
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
G
Nppa
natriuretic peptide type A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:21545725
RGD:11035217
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
severity
IEP IMP
mRNA:increased expression:kidney
RGD
PMID:22343121 PMID:22343121
RGD:14700869 , RGD:14700869
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISO
RGD
PMID:12531391
RGD:2317150
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Pax2
paired box 2
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr19:44,735,040...44,826,708
Ensembl chr19:44,735,057...44,826,310
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
mRNA:increased expression:kidney
RGD
PMID:12819032 PMID:10550325
RGD:1580850 , RGD:8554477
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Peg10
paternally expressed 10
IEP
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 6:4,747,306...4,760,517
Ensembl chr 6:4,747,306...4,760,517
G
Pkd2
polycystin 2, transient receptor potential cation channel
ISO
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
treatment
ISO
RGD
PMID:24918615
RGD:10059636
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
IEP
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Rnls
renalase, FAD-dependent amine oxidase
ISO IEP IMP
mRNA,protein:decreased expression:kidney,plasma:
RGD
PMID:23393318 PMID:23393318 PMID:23393318
RGD:7327166 , RGD:7327166 , RGD:7327166
NCBI chr19:33,115,140...33,369,695
Ensembl chr19:33,115,147...33,369,665
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
severity
ISO
RGD
PMID:26108065 PMID:26108065
RGD:11354006 , RGD:11354006
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Shh
sonic hedgehog
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
Sirt1
sirtuin 1
treatment
ISO
RGD
PMID:22324445
RGD:9495930
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Six2
sine oculis-related homeobox 2
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:85,970,276...85,995,682
Ensembl chr17:85,991,705...85,995,702
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc34a1
solute carrier family 34 (sodium phosphate), member 1
ISO
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
G
Src
Rous sarcoma oncogene
ISO
RGD
PMID:12819032
RGD:1580850
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
Stat6
signal transducer and activator of transcription 6
severity
IMP
RGD
PMID:12709397
RGD:7244143
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfb1
transforming growth factor, beta 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tlr2
toll-like receptor 2
treatment severity
ISO IDA IMP IEP
RGD
PMID:23239000 PMID:23023072 PMID:22750071 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7207894 , RGD:7207896 , RGD:7240552 , RGD:7241087
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment
ISO IMP IEP
RGD
PMID:23239000 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7240552 , RGD:7241087
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
ameliorates
ISO IEP
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 , RGD:329845564
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
IEP
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Vcam1
vascular cell adhesion molecule 1
ISO
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wt1
WT1 transcription factor
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
G
Xdh
xanthine dehydrogenase
treatment
ISO
associated with Diabetes Mellitus, Type 2
RGD
PMID:22995295 PMID:20616412
RGD:7247637 , RGD:7247695
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Zfp667
zinc finger protein 667
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:6,289,187...6,310,882
Ensembl chr 7:6,289,578...6,310,882
G
Aco1
aconitase 1
ISO
RGD
PMID:20176611
RGD:11541086
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccn2
cellular communication network factor 2
disease_progression
ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Clu
clusterin
treatment
ISO
RGD
PMID:22494435
RGD:9068431
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cs
citrate synthase
treatment
ISO
RGD
PMID:20005400
RGD:243048470
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:18209025
RGD:9685339
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
G
Pdgfa
platelet derived growth factor, alpha
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all